컴퓨터단층촬영(CT) 시장 규모, 점유율, 동향 분석 리포트 : 기술별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Computed Tomography Market Size, Share & Trends Analysis Report By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,902,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,399,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 13,391,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

CT(컴퓨터단층촬영) 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 CT 시장 규모는 2030년까지 78억 1,000만 달러에 달하며, 예측 기간 중 CAGR은 7.87%를 기록할 것으로 예측됩니다.

심혈관 질환, 암과 같은 만성질환의 부담 증가와 효과적인 이미징 툴에 대한 높은 수요는 성장을 가속하는 요인입니다. 국제암연구소에 따르면 2020년 전 세계에서 약 19,292,789명의 신규 암 환자가 발생했으며, 9,958,133명이 사망했습니다. 2025년까지 암 유병률은 50,550,287명으로 증가할 것으로 예측했습니다. 또한 예측 기간 중 응급의료 부문의 CT 시스템 수요 증가가 주요 촉진요인이 될 것으로 예상됩니다.

선량 관리 시스템, 움직임을 통한 종양 진단 기능(4D), 인공지능 통합, 고급 소재 차별화 등의 기능을 갖춘 첨단 기술이 기존의 기존 장비를 대체할 것으로 예상되며, 2021년 9월 GE헬스케어는 인공지능(AI)을 통합하여 업무 효율성과 환자 편의성을 향상시키는 기술을 탑재한 CT 시스템 '레볼루션 어센드(Revolution Ascend)'를 발표했습니다. 기술을 탑재한 CT 시스템 '레볼루션 어센드(Revolution Ascend)를 발표했습니다. 정부뿐만 아니라 민간단체의 유리한 상환 정책 증가도 시장을 유리한 속도로 견인할 것으로 예상됩니다. 경제성 개선으로 인한 외래 진단센터에 대한 수요 증가와 원격지에 대한 CT 스캐너의 보급은 추가적인 성장을 가속할 것으로 예상됩니다.

또한 대체 영상 기술은 신속한 보고가 불가능하고 동시에 비용 효율성이 낮기 때문에 성장을 가속하고 있습니다. 또한 이러한 장비와 기술은 정기적으로 업그레이드되기 때문에 예측 기간 중 수요가 더욱 증가할 것으로 예상되며, COVID-19 팬데믹이 시작된 이후 CT 스캐너에 대한 수요는 점차 증가하고 있으며, Siemens Healthineers와 같은 대기업은 매년 200대 이상의 CT 스캐너를 판매하는 것으로 알려져 있습니다. COVID-19 팬데믹으로 인해 CT 스캔 장비에 대한 수요가 크게 증가하여 지멘스는 단 45일 만에 80-100대의 CT 스캐너를 판매한 것으로 알려져 있습니다. 또한 COVID-19 환자의 흉부 CT 검사에 대한 수요가 증가함에 따라 주요 제조업체들은 CT 장비의 생산 능력을 강화했습니다.

CT 시장 보고서의 주요 내용

• 고급형 슬라이스 CT 부문이 2023년 가장 큰 시장 점유율을 차지할 것으로 예상되며, 고급 이미지 품질을 향상시키는 첨단 기술에 대한 수요 증가와 고품질 의료 서비스 제공으로의 전환이 이러한 성장에 기여하고 있습니다.
• 최종 용도별로는 병원 부문이 2023년 가장 큰 매출 점유율을 차지할 것으로 예상되며, 대규모 환자 풀과 치료 중 진단 툴로서 CT 스캐너에 대한 높은 수요가 이 부문의 성장에 기여할 것으로 예상됩니다.
• 북미가 2023년 시장을 독점한 이유는 첨단 기술 채택률이 높고, 다수 시장 기업이 존재하기 때문입니다.
• 아시아태평양은 예측 기간 중 가장 빠른 속도로 성장할 것으로 예상되며, 첨단 이미징 기술에 대한 수요 증가와 영상 진단센터 증가는 이 지역의 성장을 가속하는 요인 중 일부입니다.
• 업계 주요 기업은 인공지능 지원, 듀얼 소스 검출기 기술 기반 CT 스캐너 등 첨단 기술 및 기능 출시에 주력하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 CT 시장의 변수, 동향, 범위

• 시장 계통 전망
  • 모시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 촉진요인 분석
  • 시장 억제요인 분석
  • 시장이 해결해야 할 과제 분석
• CT 시장 분석 툴
  • 업계 분석 - Porter의 산업 분석
  • PESTEL 분석

제4장 CT 시장 : 기술 추정·동향 분석

• 기술의 시장 점유율, 2023년과 2030년
• 부문 대시보드
• 세계의 CT 시장, 기술별 전망
• 2018-2030년 시장 규모와 예측·동향 분석
• 하이엔드 슬라이스 CT
• 미드엔드 슬라이스 CT
• 로엔드 슬라이스 CT
• 콘빔 CT

제5장 CT 시장 : 용도 추정·동향 분석

• 용도의 시장 점유율, 2023년 및 2030년
• 부문 대시보드
• 세계의 CT 시장, 용도별 전망
• 2018-2030년 시장 규모와 예측·동향 분석
• 종양
• 심장병
• 혈관
• 신경
• 근골격
• 기타

제6장 CT 시장 : 최종 용도 추정·동향 분석

• 최종 용도의 시장 점유율, 2023년 및 2030년
• 부문 대시보드
• 세계의 CT 시장, 최종 용도별 전망
• 2018-2030년 시장 규모와 예측·동향 분석
• 병원
• 영상 진단 센터
• 기타

제7장 CT 시장 : 지역 추정·동향 분석

• 지역의 시장 대시보드
• 세계의 지역의 시장 스냅숏
• 2018-2030년 시장 규모와 예측·동향 분석
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제8장 경쟁 구도

• 주요 시장 참여 기업에 의한 최근 동향과 영향 분석
• 기업/경쟁 분류
• 주요 기업의 시장 점유율 분석, 2023년
• 기업 포지션 분석, 2023년
• 기업 분류(신규 기업, 이노베이터, 리더)
• 기업 개요
  • GE HealthCare
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • Canon Medical Systems
  • NeuroLogica Corp.
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Fujifilm Holdings Corporation
  • Shenzhen Anke High-tech Co., Ltd
  • Koning Health
  • Carestream Dental LLC.

KSA

영문 목차

영문목차

Computed Tomography Market Growth & Trends:

The global computed tomography market size is expected to reach USD 7.81 billion by 2030, registering a CAGR of 7.87% during the forecast period, according to a new report by Grand View Research, Inc. The increasing burden of chronic disorders, such as cardiovascular diseases and cancer, and the high demand for effective imaging tools are the factors driving growth. According to the International Agency for Cancer on Research, in 2020 globally there were about 19,292,789 new cancer cases with 9,958,133 deaths. The same source stated that the prevalence of cancer is predicted to increase to 50,550,287 by 2025. In addition, increasing demand for computed tomography (CT) systems in emergency care departments are expected to be a major driver during the forecast period.

Advanced technology with features such as dose management systems, the ability to diagnose tumors through motion (4D), artificial intelligence integration, and high-end material differentiation is expected to replace the existing conventional devices. In September 2021, GE Healthcare introduced the Revolution Ascend CT system, the technology that combines artificial intelligence (AI) to improve operational efficiency and patient comfort. The increasing number of favorable reimbursement policies by the government as well as private entities are also expected to drive the market at a lucrative pace. Growing demand for ambulatory diagnostic centers due to improving affordability and increasing reach of CT scanners to remote regions is expected to aid further growth.

Moreover, the inability of alternative imaging technologies to provide quick reports and at the same time be cost-effective boosts growth. These devices and this technology are also routinely upgraded, which is expected to further increase demand over the forecast period. Since the start of the COVID-19 pandemic, demand for CT scanners gradually increased. Large companies like Siemens Healthineers are known to sell over 200 CT scanners each year. The COVID-19 pandemic has resulted in a significant surge in CT scan equipment demand, with Siemens reporting sales of 80 to 100 units in only 45 days. Furthermore, due to increased demand for chest CT examinations in COVID-19 patients, major manufacturers increased the production capacity of the CT system.

Computed Tomography Market Report Highlights:

• The high-end slice CT segment held the largest market share in 2023, the increasing demand for advanced technology with enhanced imaging quality and the shifting focus on providing quality healthcare services has contributed to this growth
• Based on end-use, the hospital segment captured the largest revenue share in 2023, the large patient pool and high demand for CT scanners as a diagnostic tool during treatment are expected to contribute to the growth of this segment
• North America dominated the market in 2023, owing to the high adoption of advanced technology and the presence of a large number of market players are some of the factors that can be attributed to this share
• Asia Pacific is expected to grow at the fastest rate over the forecast period, growing demand for advanced imaging techniques and the rising number of diagnostic imaging centers are some of the factors driving regional growth
• Major players in the industry are focusing on the launch of advanced technology and features such as artificial intelligence-enabled, dual source-detector technology-based CT scanners.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Technology
  • 1.2.2. Application
  • 1.2.3. End-use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Technology outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Computed Tomography Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing prevalence of cancer and cardiac disease
    • 3.2.1.2. Rising geriatric population
    • 3.2.1.3. Technological advancements in the computed tomography devices
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Risk of radiation exposure
    • 3.2.2.2. Lack of skilled radiologists and high cost of medical imaging devices
  • 3.2.3. Market challenge analysis
    • 3.2.3.1. Increasing use of refurbished products
    • 3.2.3.2. Lack of regulations in the developing countries
• 3.3. Computed Tomography Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Computed Tomography Market: Technology Estimates & Trend Analysis

• 4.1. Technology Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Computed Tomography Market by Technology Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. High-end Slice CT
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Mid-end Slice CT
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Low-end Slice CT
  • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Cone Beam CT
  • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Computed Tomography Market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Computed Tomography Market by Application Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Oncology
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Cardiology
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Vascular
  • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Neurology
  • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. Musculoskeletal
  • 5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.10. Others
  • 5.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Computed Tomography Market: End-use Estimates & Trend Analysis

• 6.1. End Use Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Computed Tomography Market by End Use Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Diagnostic Imaging Centers
  • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Computed Tomography Market: Regional Estimates & Trend Analysis by Country, Technology, Application, and End-use

• 7.1. Regional Market Dashboard
• 7.2. Global Regional Market Snapshot
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework
    • 7.4.1.3. Reimbursement structure
    • 7.4.1.4. Competitive scenario
    • 7.4.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Canada
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Reimbursement structure
    • 7.4.2.4. Competitive scenario
    • 7.4.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. UK
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Reimbursement structure
    • 7.5.1.4. Competitive scenario
    • 7.5.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Reimbursement structure
    • 7.5.2.4. Competitive scenario
    • 7.5.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. France
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Reimbursement structure
    • 7.5.3.4. Competitive scenario
    • 7.5.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Italy
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Reimbursement structure
    • 7.5.4.4. Competitive scenario
    • 7.5.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. Spain
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Reimbursement structure
    • 7.5.5.4. Competitive scenario
    • 7.5.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Norway
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Reimbursement structure
    • 7.5.6.4. Competitive scenario
    • 7.5.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Reimbursement structure
    • 7.5.7.4. Competitive scenario
    • 7.5.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Regulatory framework
    • 7.5.8.3. Reimbursement structure
    • 7.5.8.4. Competitive scenario
    • 7.5.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Japan
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Reimbursement structure
    • 7.6.1.4. Competitive scenario
    • 7.6.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. China
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Reimbursement structure
    • 7.6.2.4. Competitive scenario
    • 7.6.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. India
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Reimbursement structure
    • 7.6.3.4. Competitive scenario
    • 7.6.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Australia
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Reimbursement structure
    • 7.6.4.4. Competitive scenario
    • 7.6.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Reimbursement structure
    • 7.6.5.4. Competitive scenario
    • 7.6.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Reimbursement structure
    • 7.6.6.4. Competitive scenario
    • 7.6.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Reimbursement structure
    • 7.7.1.4. Competitive scenario
    • 7.7.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Mexico
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Reimbursement structure
    • 7.7.2.4. Competitive scenario
    • 7.7.2.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Reimbursement structure
    • 7.7.3.4. Competitive scenario
    • 7.7.3.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. South Africa
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework
    • 7.8.1.3. Reimbursement structure
    • 7.8.1.4. Competitive scenario
    • 7.8.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Reimbursement structure
    • 7.8.2.4. Competitive scenario
    • 7.8.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.3. UAE
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Reimbursement structure
    • 7.8.3.4. Competitive scenario
    • 7.8.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory framework
    • 7.8.4.3. Reimbursement structure
    • 7.8.4.4. Competitive scenario
    • 7.8.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Key Company Market Share Analysis, 2023
• 8.4. Company Position Analysis, 2023
• 8.5. Company Categorization (Emerging Players, Innovators, and Leaders)
• 8.6. Company Profiles
  • 8.6.1. GE HealthCare
    • 8.6.1.1. Company overview
    • 8.6.1.2. Financial performance
    • 8.6.1.3. Product benchmarking
    • 8.6.1.4. Strategic initiatives
  • 8.6.2. Koninklijke Philips N.V.
    • 8.6.2.1. Company overview
    • 8.6.2.2. Financial performance
    • 8.6.2.3. Product benchmarking
    • 8.6.2.4. Strategic initiatives
  • 8.6.3. Siemens Healthineers AG
    • 8.6.3.1. Company overview
    • 8.6.3.2. Financial performance
    • 8.6.3.3. Product benchmarking
    • 8.6.3.4. Strategic initiatives
  • 8.6.4. Canon Medical Systems
    • 8.6.4.1. Company overview
    • 8.6.4.2. Financial performance
    • 8.6.4.3. Product benchmarking
    • 8.6.4.4. Strategic initiatives
  • 8.6.5. NeuroLogica Corp.
    • 8.6.5.1. Company overview
    • 8.6.5.2. Financial performance
    • 8.6.5.3. Product benchmarking
    • 8.6.5.4. Strategic initiatives
  • 8.6.6. Shanghai United Imaging Healthcare Co., Ltd.
    • 8.6.6.1. Company overview
    • 8.6.6.2. Financial performance
    • 8.6.6.3. Product benchmarking
    • 8.6.6.4. Strategic initiatives
  • 8.6.7. Fujifilm Holdings Corporation
    • 8.6.7.1. Company overview
    • 8.6.7.2. Financial performance
    • 8.6.7.3. Product benchmarking
    • 8.6.7.4. Strategic initiatives
  • 8.6.8. Shenzhen Anke High-tech Co., Ltd
    • 8.6.8.1. Company overview
    • 8.6.8.2. Financial performance
    • 8.6.8.3. Product benchmarking
    • 8.6.8.4. Strategic initiatives
  • 8.6.9. Koning Health
    • 8.6.9.1. Company overview
    • 8.6.9.2. Financial performance
    • 8.6.9.3. Product benchmarking
    • 8.6.9.4. Strategic initiatives
  • 8.6.10. Carestream Dental LLC.
    • 8.6.10.1. Company overview
    • 8.6.10.2. Financial performance
    • 8.6.10.3. Product benchmarking
    • 8.6.10.4. Strategic initiatives

관련자료